You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) Antibodies

Full name:
anti-Harvey Rat Sarcoma Viral Oncogene Homolog Antibodies (HRAS)
On www.antibodies-online.com are 0 Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) Antibodies from different suppliers available. Additionally we are shipping and many more products for this protein. A total of 2 Harvey Rat Sarcoma Viral Oncogene Homolog products are currently listed.
Synonyms:
C-BAS/HAS, c-H-ras, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1
list all antibodies Gene Name GeneID UniProt
Anti-Human HRAS HRAS 3265 P01112
Anti-Rat HRAS HRAS 293621 P20171

Show all synonyms

More Antibodies against Harvey Rat Sarcoma Viral Oncogene Homolog Interaction Partners

Human Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) interaction partners

  1. HRAS mutation is associated with salivary duct carcinoma.

  2. Impact of SNPs on CpG Islands in the MYC (show MYC Antibodies) and HRAS oncogenes and in a wide variety of tumor suppressor genes has been analyzed in a multi-cancer bioinformatics approach.

  3. Ras isoforms' dimer conformations are not uniform; instead, the isoform-specific dimers reflect the favoured interactions of the HVRs (hypervariable regions) with cell membrane microdomains, biasing the effector-binding site orientations, thus isoform binding selectivity.

  4. Two unrelated boys with Costello syndrome and an HRAS mutation (p.Gly13Cys) are presented with their ophthalmologic findings. Both had early symptoms of nystagmus, photophobia, and vision abnormalities

  5. The fact that no malignant tumors were described in these individuals does not allow definitive conclusions about the risk for cancer development. It remains to be determined if substitutions of amino acid 13 in HRAS (p.Gly13Asp and p.Gly13Cys) increase the risk of tumor development

  6. herefore, our results also demonstrate that the phenotype in CS and somatic cancers is not only determined by the different transforming potentials of mutant HRAS proteins, but also by the efficiency of exon 2 inclusion resulting from the different HRAS mutations.

  7. Point mutations of HRAS is associated with thyroid cancer.

  8. The results show that mutant RAS is associated with an earlier and higher rate of local tumour progression in patients undergoing ablation of CLMs.

  9. A report of three cases with pediatric urothelial bladder cancer indicates that the tumors are characterized by a consistent H-RAS mutation status, whereas FGFR3 (show FGFR3 Antibodies) and p53 (show TP53 Antibodies) pathways are not involved in this tumor initiation.

  10. The coexistence of BRAF (show BRAF Antibodies) or RAS mutations enhanced the prognostic effects of telomerase reverse transcriptase (TERT (show TERT Antibodies)) promoter mutations. Furthermore, TERT (show TERT Antibodies) promoter mutations strengthened the predictions of mortality and recurrence by the ATA and TNM (show ODZ1 Antibodies) staging systems, particularly for high-risk patients with differentiated thyroid cancer.

Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) Antigen Profile

Antigen Summary

This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, mental retardation, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene.

Alternative names and synonyms associated with Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS)

  • Harvey rat sarcoma viral oncogene homolog (HRAS) antibody
  • Harvey rat sarcoma virus oncogene (Hras) antibody
  • C-BAS/HAS antibody
  • c-H-ras antibody
  • C-HA-RAS1 antibody
  • CTLO antibody
  • H-RASIDX antibody
  • HAMSV antibody
  • HRAS1 antibody
  • K-RAS antibody
  • N-RAS antibody
  • RASH1 antibody

Protein level used designations for HRAS

GTP- and GDP-binding peptide B , GTPase HRas , H-Ras-1 , Ha-Ras1 proto-oncoprotein , Ras family small GTP binding protein H-Ras , c-has/bas p21 protein , c-ras-Ki-2 activated oncogene , p19 H-RasIDX protein , p21ras , transformation gene: oncogene HAMSV , transforming protein p21 , v-Ha-ras Harvey rat sarcoma viral oncogene homolog , Harvey ras1 protein , Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog

GENE ID SPECIES
3265 Homo sapiens
293621 Rattus norvegicus
Did you look for something else?